ProShares UltraPro QQQ ETF vs GeneDx Holdings Corp — how do they compare? ProShares UltraPro QQQ ETF trades at $71.09, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: ProShares UltraPro QQQ ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| TQQQ | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $87.22 | $167.51 |
52-Week Low | $37.89 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Trailing returns across standard periods
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →